Persistent viral infection affects tumorigenicity of a neuroblastoma cell line.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 3871358)

Published in Cell Immunol on January 01, 1985

Authors

A Schattner, B Rager-Zisman, B R Bloom

Articles by these authors

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56

Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (1966) 13.12

Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med (1994) 13.11

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity (1995) 10.65

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med (1992) 10.08

Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1992) 7.74

Genetic systems for mycobacteria. Methods Enzymol (1991) 7.50

Dissection of Mycobacterium tuberculosis antigens using recombinant DNA. Proc Natl Acad Sci U S A (1985) 7.46

Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature (1985) 6.54

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12

Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science (1993) 5.20

Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature (1995) 5.04

CD1-restricted T cell recognition of microbial lipoglycan antigens. Science (1995) 5.03

An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02

Lysogeny and transformation in mycobacteria: stable expression of foreign genes. Proc Natl Acad Sci U S A (1988) 4.90

Burden of disease--implications for future research. JAMA (2001) 4.75

Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature (1989) 4.61

Reactions in vivo and in vitro produced by a soluble substance associated with delayed-type hypersensitivity. Proc Natl Acad Sci U S A (1968) 4.57

Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46

Selective primary health care: strategies for control of disease in the developing world. V. Leprosy. Rev Infect Dis (1983) 4.40

Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun (1995) 4.28

Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol (1999) 3.96

Transfer of delayed-type hypersensitivity. A critical review and experimental study in the guinea pig. Prog Allergy (1967) 3.86

Introduction of foreign DNA into mycobacteria using a shuttle phasmid. Nature (1987) 3.83

Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect Immun (1993) 3.80

An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with Mycobacterium leprae. Proc Natl Acad Sci U S A (1996) 3.78

Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1997) 3.67

In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect Immun (1995) 3.56

Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli. Nature (1986) 3.51

In vitro approaches to the mechanism of cell-mediated immune reactions. Adv Immunol (1971) 3.49

Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39

Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun (2000) 3.39

IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol (1995) 3.29

Mutually dependent secretion of proteins required for mycobacterial virulence. Proc Natl Acad Sci U S A (2005) 3.29

Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity (1995) 3.12

Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates. J Bacteriol (1996) 2.98

Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun (1991) 2.77

Cytokine patterns of immunologically mediated tissue damage. J Immunol (1992) 2.72

Insertional mutagenesis and illegitimate recombination in mycobacteria. Proc Natl Acad Sci U S A (1991) 2.69

Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2000) 2.63

Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature (1984) 2.63

Studies on the migration inhibitory factor associated with delayed-type hypersensitivity: cytodynamics and specificity. Transplantation (1967) 2.52

An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol (1997) 2.46

Lepromin-induced suppressor cells in patients with leprosy. J Immunol (1979) 2.45

The evolving relation between humans and Mycobacterium tuberculosis. N Engl J Med (1998) 2.39

The Fc receptors of primary and cultured phagocytic cells studied with homogeneous antibodies. J Immunol (1978) 2.38

Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J Immunol (1976) 2.34

Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A (1994) 2.33

Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae. Infect Immun (1987) 2.30

Genetic relationships among Mycobacterium leprae, Mycobacterium tuberculosis, and candidate leprosy vaccine strains determined by DNA hybridization: identification of an M. leprae-specific repetitive sequence. Infect Immun (1989) 2.29

Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc Natl Acad Sci U S A (1996) 2.27

Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence. Infect Immun (1994) 2.26

Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci U S A (1989) 2.21

A novel transposon trap for mycobacteria: isolation and characterization of IS1096. J Bacteriol (1991) 2.20

Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci U S A (2000) 2.20

Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A (1995) 2.17

On the heterogeneity of murine natural killer cells. J Exp Med (1981) 2.15

A plaque assay for enumerating antigen-sensitive cells in delayed-type hypersensitivity. J Exp Med (1970) 2.15

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci U S A (1998) 2.13

Games parasites play: how parasites evade immune surveillance. Nature (1979) 2.04

Macrophage variants in oxygen metabolism. J Exp Med (1980) 2.04

Structure of the heat shock protein chaperonin-10 of Mycobacterium leprae. Science (1996) 2.03

Migration inhibitory factor associated with delayed-type hypersensitivity. Fed Proc (1990) 2.02

Immunological unresponsiveness in leprosy. Immunol Rev (1984) 2.02

Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients. J Immunol (1980) 2.02

Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol (1993) 2.00

Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci U S A (1978) 1.97

Interferon-gamma-induced transcriptional activation is mediated by protein kinase C. Proc Natl Acad Sci U S A (1988) 1.97

The major native proteins of the leprosy bacillus. J Biol Chem (1990) 1.96

Tuberculosis. Back to a frightening future. Nature (1992) 1.95

Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1998) 1.94

A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med (1992) 1.93

Virus-induced autoimmunity. Rev Infect Dis (1990) 1.93

Auxotrophic vaccines for tuberculosis. Nat Med (1996) 1.89

Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol (1993) 1.88

Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet (1992) 1.87

Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc Natl Acad Sci U S A (1999) 1.84

Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82

Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med (1979) 1.81

Immunological destruction of herpes simplex virus I infected cells. Nature (1974) 1.80

The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol (1981) 1.79

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63. Proc Natl Acad Sci U S A (1993) 1.76

Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1996) 1.76

Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria. J Clin Microbiol (1996) 1.76

A useful quantitative semimicromethod for viral plaque assay. Proc Soc Exp Biol Med (1973) 1.73

Oxygen metabolism in cloned macrophage cell lines: glucose dependence of superoxide production, metabolic and spectral analysis. J Immunol (1984) 1.73

V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol (1995) 1.73

Dual immunological unresponsiveness induced by cell membrane coupled hapten or antigen. Nature (1966) 1.68

The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus. J Gen Virol (1973) 1.68

Enumeration of activated thymus-derived lymphocytes by the virus plaque assay. Proc Natl Acad Sci U S A (1973) 1.67

Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A (2000) 1.65

Mode of regulation of natural killer cell activity by interferon. J Exp Med (1980) 1.63

Learning from lesions: patterns of tissue inflammation in leprosy. Proc Natl Acad Sci U S A (1988) 1.62

Dissociation of MIF production and cell proliferation. J Immunol (1972) 1.62

Role of macrophage oxidative burst in the action of anthrax lethal toxin. Mol Med (1994) 1.60

Research evidence and the individual patient. QJM (2003) 1.59

Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases. Lancet (1981) 1.59